Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stéphane Collaud has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mediastinal tracheostomy: techniques, outcomes and quality of life—a systematic review

    by Jonas Peter Ehrsam, Ana-Maria Petrone, Marko Aleksic, Paul Christian Fuchs, Steffen Maune, Theresa Stork, Stéphane Collaud

    Background: Mediastinal tracheostomy (MT) is a rare, technically demanding salvage procedure in which the distal trachea is redirected into the upper mediastinum. It is indicated when extensive resection of the proximal trachea precludes conventional tracheal reconstruction or cervical tracheostomy. It is performed for a variety of underlying diseases. The aim of this systematic review was to summarize the available evidence on operative techniques, perioperative outcomes, disease-specific outcomes, and quality of life. Methods: A systematic review was conducted. PubMed was searched for case reports and case series. Data on surgical techniques, indications, perioperative outcomes, complications, and quality of life were descriptively analyzed. Results: Seventy publications reporting 437 mediastinal tracheostomies over 85 years were identified. Of these, 429 were permanent anterior mediastinal tracheostomies, the predominant type. Several techniques have evolved for this procedure over time. Extended manubrial resection was performed in most cases, whereas hemi-manubrial resection (2.8%) has gained popularity in recent years. Although a tracheal stump length of ≥5 cm is generally recommended, 12.6% of tracheostomies were created with a stump measuring 0–4 cm. Tracheal transposition was performed in 52.9% of cases to increase tracheal length and avoid contact with the brachiocephalic artery. Initially, direct collar skin (20.3%) or bipedicled upper thoracic skin flaps (13.8%) were used for reconstruction; more recently, the pectoralis major myocutaneous flap (32.9%) has become the predominant technique. Postoperative mortality was 7.0% and decreased over time. Major complications included great vessel rupture (6.8%), tracheal necrosis (8.4%), and tracheal stenosis (9.6%). Patients with a tracheal stump length of 0–3cm had a failure rate of 33.3%. Available data did not permit reliable conclusions on outcomes for specific malignancy types. Quality-of-life data were scarce, although individual reports described independent daily living and return to strenuous work for more than 10 years. Conclusions: Permanent anterior MT remains the standard form of MT and can provide acceptable outcomes when meticulous surgical technique is applied. Tracheal transposition and well-vascularized muscle flap reconstruction appear to reduce procedure-related complications, particularly in patients with short tracheal remnants. Prospective multicenter studies are needed to define optimal surgical strategies, long-term oncological outcomes, and patient-reported quality of life.

  • Open Access

    Outcome of segmentectomy vs. lobectomy in patients with cT1a-b N0 lung cancer and postoperative N1 upstaging

    by Hafsa Kaman, Theresa Stork, Özlem Okumus, Mehran Jemsi, Ana-Maria Petrone, Yazan Alnajdawi, Stéphane Collaud

    Purpose: Segmentectomy is offered in selected patients with clinical T1a-b N0 M0 lung cancer. In case of positive N1 lymph node at fresh frozen section, conversion to lobectomy is recommended. Indication for redo surgery and completion lobectomy in case of positive N1 lymph node at final pathology is highly debated. We aim to compare the outcome between segmentectomy and lobectomy in patients with cT1a–b N0 M0 lung cancer with postoperative N1-upstaging. Methods: We retrospectively reviewed all patients with pT1a-b N1cM0 lung cancer who underwent surgical resection with lymph node dissection between January 2013 and January 2024 at our institution. We included patients with tumor size ≤ 2 cm and postoperative N1-upstaging. Disease-free (DFS) and overall (OS) survivals were calculated from the date of surgery until recurrence or death and were compared between the groups. Results: Twenty-five patients with cT1a-b N0 M0 lung cancer and postoperative N1-upstaging were identified. Median age was 64 years (42–81). Sixteen (64%) patients underwent lobectomy There was no significant difference in tumor size (median: 1,1, IQR $$\:[$$ 1,1–1,8 $$\:]$$ vs. 1,5, IQR $$\:[$$ 1,4 − 1,8 $$\:]$$ , p = 0.186) and FEV1% (median: 76, IQR $$\:[$$ 74- 92 $$\:]$$ vs. 75, IQR $$\:[$$ 69- 87 $$\:]$$ , p = 0.656) between segmentectomy and lobectomy groups. Number of lymph nodes removed was significantly lower in the segmentectomy group (median: 10, IQR $$\:[$$ 4- 26 $$\:]$$ vs. 23, IQR $$\:[$$ 14- 32 $$\:]$$ p = 0.035). Median follow-up was 53, IQR $$\:[$$ 41- 63 $$\:]$$ months. There was no difference in 5-year DFS (72.9%vs 70.5%, p = 0.502) and OS (85,7%vs. 85,6%, p = 0.233) between the groups. Conclusion: In patients who underwent segmentectomy or lobectomy for cT1a-b N0 M0 lung cancer and postoperative N1-upstaging, no difference in survivals was seen in our cohort.

  • Open Access

    Computer tomography-based three-dimensional reconstruction of an extended AB-thymoma: a case report

    by Özlem Okumus, Thomas P H Koester, Hafsa Kaman, Theresa Stork, Stéphane Collaud

    Thymomas are rare malignancies, constituting nearly half of anterior mediastinal tumors. We present a case of a large AB-Thymoma infiltrating adjacent structures. We evaluated computer tomography (CT)-based three-dimensional (3D) reconstruction to assess its utility in preoperative planning. The reconstructed images elucidated the spatial relationships between the tumor and surrounding structures and the findings from the reconstruction aligned with the surgical resection extent. Due to inherent imaging modality, the reconstruction had limitations in visualizing nerves and the pericardium. Nevertheless, 3D CT-based reconstruction of mediastinal tumors enhanced surgical planning by providing a detailed roadmap, facilitating preoperative discussions with patients, and serving as an educational tool for medical students.

  • Open Access

    Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study

    by Stephane Collaud, Theresa Stork, Dagmar Adamkova, Clemens Aigner, Ivan Bravio, Antonella Brunello, Luigi Cerbone, Hugo Clermidy, Lore De Cock, Silvia Gasperoni, et al.


  • Open Access

    Segmentectomy is associated with worse disease-free survival compared to lobectomy in patients with stage IA3 non-small cell lung cancer

    by Kaman Hafsa, Stork Theresa, Okumus Özlem, Alnajdawi Yazan, Jemsi Mehran, Petrone Ana, Collaud Stéphane, Stéphane Collaud

    Purpose: Segmentectomy has become the new standard of care for selected patients with stage IA1-2 non-small cell lung cancer (NSCLC). For stage IA3 NSCLC, lobectomy is indicated. This study aims to compare the outcome after segmentectomy and lobectomy in patients with stage IA3 NSCLC. Methods: We retrospectively reviewed all patients undergoing surgery for NSCLC in our center between 2013 and 2023. We identified all patients who underwent segmentectomy or lobectomy for pathological stage IA3 tumors. Survival was calculated from the date of surgery until last follow- up. Univariate analysis was performed to study the impact on overall survival (OS) and disease-free survival (DFS) of clinical variables. Results: We identified fifty-nine patients undergoing surgery for stage IA3 NSCLC. Twenty- seven (28%) patients underwent segmentectomy and sixty-eight (72%) patients underwent lobectomy. Median age was 68 years (47–85). Median FEV1 was 74% (39–140), median DLCO was 67% (28–128). Surgery was performed by VATS in most cases (91%). There was no difference in age and lung function between the lobectomy and segmentectomy groups. Five-year OS was 67%. 5-year DFS was 63%. Five-year DFS was significantly worse in patients who underwent segmentectomy compared to lobectomy (37% vs. 72%, p = 0.040). There was no difference in 5-year OS (56% vs. 69%, p = 0.56). Conclusion: Segmentectomy is associated with significantly worse disease-free survival compared to lobectomy in our cohort of patients with stage IA3 NSCLC.


  • Open Access

    Primary Mediastinal Ewing’s Sarcoma: Post Hoc Analysis from Two International Multicenter Prospective Randomized Trials

    by Theresa Stork, Andreas Ranft, Clemens Aigner, Heribert Jurgens, Ruth L. Ladenstein, Beate Timmermann, Henk Van Den Berg, Uta Dirksen, Stéphane Collaud

    Objective: Ewing sarcoma (EWS) of the mediastinum is extremely rare, with only a few cases reported in the literature. We aimed to gain a better understanding of primary mediastinal EWS, describing patients treated within two international, multicenter, prospective, randomized EWS trials. Methods: Data from patients with primary mediastinal EWS were retrieved from the database of the EURO-E.W.I.N.G.99 (ClinicalTrials.gov identifier: NCT00020566) and EWING 2008 (ClinicalTrials.gov identifier: NCT00987636) trials. Patient and treatment characteristics were analyzed. Results: Out of 2969 patients with EWS, 9 (0.3%) had primary mediastinal EWS. The median age at diagnosis was 30.5 years (4 to 49). At the time of diagnosis, n = 3 (33%) patients had synchronous metastases. All patients underwent multiagent chemotherapy. Local therapy for non-metastatic patients was surgery (n = 2, 22%), surgery and radiotherapy (n = 2, 22%) or radiotherapy alone (n = 2, 22%). Surgery consisted of extended resections in most patients (n = 3, 33%). Five-year survival for the whole cohort was 64%. Apart from one patient who was lost to follow-up, all patients (n = 4) who had undergone surgery were alive at the end of follow-up. Conclusions: Primary mediastinal ES is extremely rare, with a prevalence of 0.3% among EWS. Five-year survival was favorable compared to primary mediastinal sarcoma of all histologies and in line with EWS of different origin.


  • Open Access

    Giant middle mediastinal lesions: when tumor size correlates with mesenchymal origin—a retrospective single-center analysis

    by Stéphane Collaud, Theresa Stork, Hafsa Kaman, Sebastian Bauer, Christoph Pöttgen, Hans-Ulrich Schildhaus, Bastian Schmack, Clemens Aigner

    Background: The International Thymic Malignancy Interest Group (ITMIG) proposed an internationally accepted division of the mediastinum into three compartments based on computed tomography (CT): anterior (prevascular), middle (visceral) and posterior (paravertebral) compartment. There is no generally accepted definition for the term “giant” when applied to middle mediastinal lesions. We defined the term “giant” and described our surgical experience in treating patients with giant lesions of the middle mediastinum. Methods: CT imaging of patients operated in our center from January 2016 to August 2021 for mediastinal lesions was reviewed. Lesions were categorized to one of the ITMIG-defined compartments. Lesion size at diagnosis was measured at its largest diameter on axial CT imaging. Giant middle mediastinal lesions were defined as lesions having a size ≥90th percentile of our middle mediastinal lesion cohort. Patients with giant middle mediastinal lesions were further analyzed. Results: Thirty-six patients (23%) had lesions located in the middle mediastinal compartment. Most common diagnoses were mediastinal cysts (n=10, 28%), metastatic lesions (n=6, 17%), lymphomas (n=5, 14%), and sarcomas (n=3, 8%). Ninetieth percentile lesion size was 73 mm. As per definition, four patients had giant middle mediastinal lesions. All these four lesions were of mesenchymal origin including oesophageal leiomyoma, synovial sarcoma, leiomyosarcoma and undifferentiated round cell sarcoma. Resection was performed through posterolateral thoracotomy or sternotomy, with or without cardiopulmonary bypass. Conclusions: The term “giant” could be defined as a mass larger or equal to 73 mm. This definition selected specifically lesions with mesenchymal origin and may therefore guide diagnostic algorithm and patient management.